Caplin Point Laboratories Limited — Clarithromycin Exporter Profile
Indian Pharmaceutical Exporter · #4 for Clarithromycin · $5.5M export value · DGFT Verified
Caplin Point Laboratories Limited is the #4 Indian exporter of Clarithromycin with $5.5M in export value and 110 verified shipments. Caplin Point Laboratories Limited holds a 5.6% market share in Clarithromycin exports across 10 countries. The company exports 55 pharmaceutical products worth $174.5M across 20 therapeutic categories.
Caplin Point Laboratories Limited — Clarithromycin Export Profile: Buyers & Destinations
Where Does Caplin Point Laboratories Limited Export Clarithromycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| EL SALVADOR | $1.0M | 28 | 27.4% |
| CHILE | $685.6K | 15 | 18.5% |
| DOMINICAN REPULIC | $379.9K | 11 | 10.3% |
| COSTA RICA | $346.1K | 8 | 9.3% |
| NICARAGUA | $291.5K | 8 | 7.9% |
| GUATEMALA | $260.5K | 9 | 7.0% |
| ECUADOR | $259.5K | 8 | 7.0% |
| GAUTEMALA | $254.1K | 14 | 6.9% |
| DOMINICAN REPUBLIC | $100.0K | 2 | 2.7% |
| HONDURAS | $98.5K | 4 | 2.7% |
Caplin Point Laboratories Limited exports Clarithromycin to 12 countries. The largest destination is EL SALVADOR accounting for 27.4% of Caplin Point Laboratories Limited's Clarithromycin shipments, followed by CHILE (18.5%) and DOMINICAN REPULIC (10.3%). These destinations reflect Caplin Point Laboratories Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Clarithromycin from Caplin Point Laboratories Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| DROGUERIA SAIMED S.A. DE C.V., | EL SALVADOR | $670.6K | 17 |
| VITAFARMA S.A. | CHILE | $448.9K | 10 |
| SALDENT INTERNACIONAL S.R.L., | DOMINICAN REPULIC | $429.9K | 12 |
| DROGUERIA SAIMED S A DE C V | EL SALVADOR | $258.5K | 7 |
| NUEVOS ETICOS NEOETHICALS, S.A. | HONDURAS | $254.6K | 10 |
| CAPLIN POINT COSTA RICA S A | COSTA RICA | $191.0K | 4 |
| NUEVOS ETICOS NEOETHICALS S A | GAUTEMALA | $182.3K | 7 |
| NEOETHICALS CIA LTDA | ECUADOR | $177.4K | 4 |
| NEOETHICALS, S.A, | NICARAGUA | $159.9K | 4 |
| LABORATORIO HOSPIFARMA CHILE LTDA | CHILE | $136.7K | 3 |
Caplin Point Laboratories Limited supplies Clarithromycin to 23 buyers globally. The largest buyer is DROGUERIA SAIMED S.A. DE C.V., (EL SALVADOR), followed by VITAFARMA S.A. (CHILE) and SALDENT INTERNACIONAL S.R.L., (DOMINICAN REPULIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Clarithromycin Export Value and How Much Does Caplin Point Laboratories Limited Contribute?
India exported $61.2M worth of Clarithromycin through 3,576 shipments from 334 suppliers to 144 countries, serving 811 buyers globally. Caplin Point Laboratories Limited contributes $5.5M to this total, accounting for 5.6% of India's Clarithromycin exports. Caplin Point Laboratories Limited ships Clarithromycin to 12 countries through 23 buyers.
What Is the Average Shipment Value for Caplin Point Laboratories Limited's Clarithromycin Exports?
Caplin Point Laboratories Limited's average Clarithromycin shipment value is $50.0K per consignment, based on 110 shipments totaling $5.5M. The largest destination is EL SALVADOR (27.4% of Caplin Point Laboratories Limited's Clarithromycin exports).
How Does Caplin Point Laboratories Limited Compare to Other Indian Clarithromycin Exporters?
Caplin Point Laboratories Limited ranks #4 among 334 Indian Clarithromycin exporters with a 5.6% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($15.4M), MICRO LABS LIMITED ($15.4M), AUROBINDO PHARMA LTD ($7.8M). Caplin Point Laboratories Limited processed 110 shipments to 10 destination countries.
What Clarithromycin Formulations Does Caplin Point Laboratories Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CLARITHROMYCIN TABLETS USP 500MG | $2.0M | 50 |
| CLARITHROMYCIN FOR ORAL SUSPENSION USP 250MG/5ML | $461.4K | 13 |
| CLARITHROMYCIN FOR ORAL SUSPENSION USP 2 | $381.3K | 12 |
| CLARITHROMYCIN TABLETS USP 500MG CLARITROMICINA TABLETAS RECUBIERTAS 500MG (COCLARIT 500) (CLARITROMICINA USP 500MG) ITENOS | $192.0K | 7 |
| CLARITHROMYCIN FOR ORAL SUSPENSION USP 250MG 5ML | $148.6K | 6 |
| CLARITHROMYCIN TABLETS USP 500MG CLARITR | $137.9K | 3 |
| CLARITHROMYCIN TABLETS USP 500MGNOS | $111.7K | 6 |
| CLARITHROMYCIN TABLETS USP 500 MG | $56.1K | 2 |
| CLARITHROMYCIN TABLETS USP 500MG CLARITROMICINA TABLETAS RECUBIERTAS 500MG - ITEM CODE : 171000671 | $51.2K | 2 |
| CLARITHROMYCIN TABLETS USP 500MG CLARITROMICINA TABLETAS RECUBIERTAS 500MG (COCLARIT 500) - ITEM CODE : 171000855 | $50.0K | 1 |
Caplin Point Laboratories Limited exports 18 distinct Clarithromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CLARITHROMYCIN TABLETS USP 500MG with 50 shipments worth $2.0M.
How Does Caplin Point Laboratories Limited Compare to Nearest Clarithromycin Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MICRO LABS LIMITED | $15.4M | 308 | 27 | $50.0K |
| 3 | AUROBINDO PHARMA LTD | $7.8M | 183 | 10 | $42.6K |
| 4 | CAPLIN POINT LABORATORIES LIMITED ★ | $5.5M | 110 | 10 | $50.0K |
| 7 | AJANTA PHARMA LIMITED | $4.0M | 109 | 9 | $36.6K |
| 10 | IND SWIFT LIMITED | $2.9M | 124 | 23 | $23.0K |
Caplin Point Laboratories Limited ranks #4 among 334 Indian Clarithromycin exporters. Average shipment value of $50.0K compared to the market average of $183.3K. The closest competitors by value are MICRO LABS LIMITED and AUROBINDO PHARMA LTD.
Which Indian Ports Ship Clarithromycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 365 | 10.2% |
| DELHI AIR CARGO ACC (INDEL4) | 296 | 8.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 282 | 7.9% |
| DELHI AIR | 258 | 7.2% |
| NHAVA SHEVA SEA (INNSA1) | 229 | 6.4% |
| JNPT/ NHAVA SHEVA SEA | 156 | 4.4% |
| JNPT | 125 | 3.5% |
| DHANNAD ICD | 124 | 3.5% |
What Other Antibiotics Products Does Caplin Point Laboratories Limited Export?
Caplin Point Laboratories Limited also exports these antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Caplin Point Laboratories Limited's Clarithromycin Exports
The global pharmaceutical export landscape is currently navigating several geopolitical challenges that directly impact companies like Caplin Point.
The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing maritime carriers to suspend bookings and reroute vessels around the Cape of Good Hope. This has resulted in elongated lead times and increased shipping costs, disproportionately affecting time-sensitive pharmaceutical shipments. Freight charges have surged, with transport costs doubling and additional surcharges ranging from $4,000 to $8,000 per shipment. Such disruptions pose significant risks to the timely delivery of pharmaceuticals, especially those requiring stringent cold-chain logistics. (pharmaceuticalcommerce.com)
In the United States, recent tariff implementations have introduced further complexities. The U.S. administration has imposed broad tariffs on imports from over 60 countries, including India, with rates reaching up to 39%. These tariffs affect a substantial portion of Indian exports to the U.S., including pharmaceuticals, potentially leading to increased costs and competitive disadvantages for Indian exporters. (apnews.com)
The European Union's regulatory landscape is also evolving, with stricter compliance requirements under directives like the Falsified Medicines Directive. Indian pharmaceutical companies must invest in advanced serialization and traceability systems to meet these standards, ensuring continued access to the lucrative EU market.
For Caplin Point, these geopolitical and regulatory developments necessitate strategic adaptations. Diversifying export markets, enhancing supply chain resilience, and investing in compliance infrastructure are critical to mitigating risks and sustaining growth in this volatile environment.
Caplin Point Laboratories Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, particularly from agencies like the U.S. FDA and the European Medicines Agency. Compliance with Good Manufacturing Practices (GMP) and other quality standards is imperative for market access.
Caplin Point has proactively addressed these requirements. The company's subsidiary, Caplin Steriles Limited (CSL), has secured an EU GMP renewal and successfully passed audits by regulatory bodies such as the Saudi FDA. These achievements underscore Caplin Point's commitment to maintaining high-quality standards and ensuring compliance with international regulations. (whalesbook.com)
However, the broader Indian pharmaceutical sector faces challenges related to quality and compliance. The U.S. FDA conducted over 200 inspections in India in 2023, with plans to increase this number in subsequent years. Instances of substandard products have led to increased scrutiny, emphasizing the need for continuous quality improvements. (fact.net.in)
For Caplin Point, ongoing investment in quality assurance systems, employee training, and infrastructure upgrades is essential to navigate the evolving regulatory landscape and maintain its competitive edge.
About Caplin Point Laboratories Limited
Caplin Point Laboratories Limited exports 55 products worth $174.5M. Beyond Clarithromycin, top products include Ibuprofen, Diclofenac, Clotrimazole, Potassium, Vitamin. View the complete Caplin Point Laboratories Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Clarithromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Clarithromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Caplin Point Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 110 individual customs records matching Caplin Point Laboratories Limited exporting Clarithromycin, covering 18 formulations to 12 countries via 23 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 144+ countries, 811+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Clarithromycin Export Data from Caplin Point Laboratories Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Caplin Point Laboratories Limited's Clarithromycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Caplin Point Laboratories Limited
Full Company Profile →
55 products · $174.5M total trade · 20 categories
Clarithromycin Stats
Company Overview
Top Products by Caplin Point Laboratories Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Caplin Point Laboratories Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Clarithromycin. For current shipment-level data, contact TransData Nexus.